Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 18, 2026 | BlueCross BlueShield of Tennessee | Agalsidase Beta(Fabrazyme) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Aflibercept Products (Eylea; EyleaHD, Ahzantive [aflibercept-mrbb], Enzeevu [Aflibercept-abzv], Eydenzelt [Aflibercept-boav], Opuviz [Aflibercept-yszy], Pavblu [Aflibercept-ayyh], and Yesafili [Aflibercept-jbvf]) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Afamitresgene Autoleucel (Tecelra) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Nadofaragene firadenovec-vncg (Adstiladrin) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Ado-Trastuzumab Emtansine (Kadcyla) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | ADAMTS13, recombinant-krhn (Adzynma) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Crizanlizumab-tmca(Adakveo) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Corticotropin-ACTH: [HP Acthar Gel (repository corticotropin injection), Cortrophin Gel | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Paclitaxel (Albumin-Bound) (Abraxane; Paclitaxel Albumin-Bound) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | AbobotulinumtoxinA (Dysport) | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Ablation Procedure for Peripheral Neuromas | Criteria changed |
| May 18, 2026 | BlueCross BlueShield of Tennessee | Idecabtagene Vicleucel (Abecma) | Criteria changed |
| May 18, 2026 | Carelon Medical Benefits Management | Radiation Therapy for Non-Malignant Disease | Criteria changed |
| May 18, 2026 | Carelon Medical Benefits Management | Radiation Therapy (excludes Proton) | Criteria changed |
| May 18, 2026 | Carelon Medical Benefits Management | Perirectal Hydrogel Spacer for Prostate Radiotherapy | Criteria changed |
| May 18, 2026 | Carelon Medical Benefits Management | Site of Care for Surgical Procedures | Criteria changed |
| May 18, 2026 | Carelon Medical Benefits Management | Wearable Cardioverter Defibrillators [for Wellpoint Massachusetts] | Criteria changed |
| May 18, 2026 | Carelon Medical Benefits Management | Diagnostic Coronary Angiography | Criteria changed |
| May 18, 2026 | Carelon Medical Benefits Management | Febrile Neutropenia Risk | Criteria changed |
| May 18, 2026 | Carelon Medical Benefits Management | Proton Beam Therapy | Criteria changed |
| May 18, 2026 | Carelon Medical Benefits Management | Whole Exome Sequencing and Whole Genome Sequencing | Criteria changed |
| May 18, 2026 | Carelon Medical Benefits Management | Pharmacogenetic Testing | Criteria changed |
| May 18, 2026 | Carelon Medical Benefits Management | Carrier Screening in the Reproductive Setting [for Wellpoint Massachusetts] | Criteria changed |
| May 18, 2026 | Carelon Medical Benefits Management | Carrier Screening in the Reproductive Setting | Criteria changed |
| May 18, 2026 | Carelon Medical Benefits Management | Sacroiliac Joint Fusion | Criteria changed |
| May 18, 2026 | Carelon Medical Benefits Management | Interventional Pain Management | Criteria changed |
| May 18, 2026 | Carelon Medical Benefits Management | Percutaneous Coronary Intervention [for Wellpoint Massachusetts] | Criteria changed |
| May 18, 2026 | Carelon Medical Benefits Management | Implantable Cardioverter Defibrillators | Criteria changed |
| May 18, 2026 | Carelon Medical Benefits Management | Dialysis Access Evaluations | Criteria changed |
| May 18, 2026 | Carelon Medical Benefits Management | Cardiac Resynchronization Therapy [for WellPoint Massachusetts] | Criteria changed |
| May 18, 2026 | Carelon Medical Benefits Management | Ambulatory Cardiac Rhythm Monitoring | Criteria changed |
| May 18, 2026 | Carelon Medical Benefits Management | Site of Care for Advanced Imaging | Criteria changed |
| May 18, 2026 | Carelon Medical Benefits Management | Imaging of the Extremities [for Wellpoint Massachusetts] | Criteria changed |
| May 18, 2026 | Carelon Medical Benefits Management | Imaging of the Extremities | Criteria changed |
| May 18, 2026 | Carelon Medical Benefits Management | Imaging of the Brain | Criteria changed |
| May 18, 2026 | Moda Health | Zynyz (retifanlimab-dlwr) | Criteria changed |
| May 18, 2026 | Moda Health | Zynteglo (betibeglogene autotemcel) | Criteria changed |
| May 18, 2026 | Moda Health | Zynlonta (loncastuximab tesirine-lpyl) | Criteria changed |
| May 18, 2026 | Moda Health | Zusduri (mitomycin) | Criteria changed |
| May 18, 2026 | Moda Health | Zulresso (brexanalone) | Criteria changed |
| May 18, 2026 | Moda Health | Ziihera (zanidatamab-hrii) | Criteria changed |
| May 18, 2026 | Moda Health | Zevaskyn (prademagene zamikeracel) | Criteria changed |
| May 18, 2026 | Moda Health | Zepzelca (lurbinectedin) | Criteria changed |
| May 18, 2026 | Moda Health | Zolgensma (onasemnogene abeparvovec-xioi) | Criteria changed |
| May 18, 2026 | Moda Health | Zaltrap (ziv-aflibercept) | Criteria changed |
| May 18, 2026 | Moda Health | Zilretta (triamcinolone acetonide ER) | Criteria changed |
| May 18, 2026 | Moda Health | Trabectedin Evdi; Yondelis | Criteria changed |
| May 18, 2026 | Moda Health | Yescarta (axicabtagene ciloleucel) | Criteria changed |
| May 18, 2026 | Moda Health | Yervoy (ipilimumab) | Criteria changed |
| May 18, 2026 | Moda Health | Yartemlea (narsoplimab-wuug) | Criteria changed |